personalized neoantigen peptide vaccine (Translational Genomics Research Institute/City of Hope)

N/A

Report date: 2025/06/11 10:21:31

Base Information

Drug Namepersonalized neoantigen peptide vaccine (Translational Genomics Research Institute/City of Hope)
Drug Alias Namecancer vaccine (Translational Genomics Research Institute/City of Hope)SVAC-101
ClassificationBiologics > Antigen > Tumor antigenVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine +[4] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTranslational Genomics Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesCity of HopeTranslational Genomics Research Institute
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A